$\require{mediawiki-texvc}$

연합인증

연합인증 가입 기관의 연구자들은 소속기관의 인증정보(ID와 암호)를 이용해 다른 대학, 연구기관, 서비스 공급자의 다양한 온라인 자원과 연구 데이터를 이용할 수 있습니다.

이는 여행자가 자국에서 발행 받은 여권으로 세계 각국을 자유롭게 여행할 수 있는 것과 같습니다.

연합인증으로 이용이 가능한 서비스는 NTIS, DataON, Edison, Kafe, Webinar 등이 있습니다.

한번의 인증절차만으로 연합인증 가입 서비스에 추가 로그인 없이 이용이 가능합니다.

다만, 연합인증을 위해서는 최초 1회만 인증 절차가 필요합니다. (회원이 아닐 경우 회원 가입이 필요합니다.)

연합인증 절차는 다음과 같습니다.

최초이용시에는
ScienceON에 로그인 → 연합인증 서비스 접속 → 로그인 (본인 확인 또는 회원가입) → 서비스 이용

그 이후에는
ScienceON 로그인 → 연합인증 서비스 접속 → 서비스 이용

연합인증을 활용하시면 KISTI가 제공하는 다양한 서비스를 편리하게 이용하실 수 있습니다.

[해외논문] Limitation of Infarct Size in Rabbit Hearts by the Novel Adenosine Receptor Agonist AMP 579 Administered at Reperfusion

Journal of molecular and cellular cardiology, v.32 no.12, 2000년, pp.2339 - 2347  

Xu, Zhelong (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) ,  Yang, Xi-Ming (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) ,  Cohen, Michael V (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) ,  Neumann, Till (Department of Pathophysiology, University of Essen, Essen, Germany) ,  Heusch, Gerd (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA) ,  Downey, James M (Department of Physiology, University of South Alabama, College of Medicine, Mobile, AL 36688, USA)

Abstract AI-Helper 아이콘AI-Helper

AbstractThe novel A1/A2adenosine receptor agonist AMP 579 has been reported to reduce myocardial infarct size in pig and dog. The present study tested the effect of AMP 579 in two rabbit models. In open-chest rabbits undergoing 30 min of regional ischemia and 3 h of reperfusion AMP 579 (3 μ g...

주제어

참고문헌 (25)

  1. Circulation Toombs 86 986 1992 10.1161/01.CIR.86.3.986 Myocardial protective effects of adenosine: infarct size reduction with pretreatment and continued receptor stimulation during ischemia 

  2. Circulation Thornton 85 659 1992 10.1161/01.CIR.85.2.659 Intravenous pretreatment with A1-selective adenosine analogues protects the heart against infarction 

  3. Circulation Olafsson 76 1135 1987 10.1161/01.CIR.76.5.1135 Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon 

  4. Circulation Pitarys 83 237 1991 10.1161/01.CIR.83.1.237 Reduction of myocardial reperfusion injury by intravenous adenosine administered during the early reperfusion period 

  5. Coron Artery Dis Zhao 10 617 1999 10.1097/00019501-199912000-00011 Administration of adenosine during reperfusion reduces injury of vascular endothelium and death of myocytes 

  6. Cardiovasc Res Goto 25 943 1991 10.1093/cvr/25.11.943 Adenosine infusion during early reperfusion failed to limit myocardial infarct size in a collateral deficient species 

  7. Cardiovasc Res Vander Heide 31 711 1996 10.1016/S0008-6363(95)00235-9 Effect of adenosine therapy at reperfusion on myocardial infarct size in dogs 

  8. J Pharmacol Exp Ther Smits 286 611 1998 Cardioprotective effects of the novel adenosine A1/A2receptor agonist AMP 579 in a porcine model of myocardial infarction 

  9. J Cardiovasc Pharmacol McVey 33 703 1999 10.1097/00005344-199905000-00005 Cardiovascular pharmacology of the adenosine A1/A2-receptor agonist AMP 579: coronary hemodynamic and cardioprotective effects in the canine myocardium 

  10. Am J Physiol Jordan 277 H1895 1999 A3adenosine receptor activation attenuates neutrophil function and neutrophil-mediated reperfusion injury 

  11. J Mol Cell Cardiol Shirato 21 1187 1989 10.1016/0022-2828(89)90695-0 Tetrazolium artifactually indicates superoxide dismutase-induced salvage in reperfused rabbit heart 

  12. Basic Res Cardiol Miki 94 180 1999 10.1007/s003950050141 Failure of N-2-mercaptopropionyl glycine to reduce myocardial infarction after 3 days of reperfusion in rabbits 

  13. Washington: National Academy Press National Research Council 1996 Guide for the care and use of laboratory animals 

  14. Circulation Weinbrenner 98 899 1998 10.1161/01.CIR.98.9.899 Fostriecin, an inhibitor of protein phosphatase 2A, limits myocardial infarct size even when administered after onset of ischemia 

  15. Cardiovasc Res Weinbrenner 38 676 1998 10.1016/S0008-6363(98)00064-9 Cyclosporine A limits myocardial infarct size even when administered after onset of ischemia 

  16. Am J Physiol Zhao 273 H1677 1997 Adenosine inhibition of neutrophil damage during reperfusion does not involve KATP-channel activation 

  17. Am Heart J Norton 123 332 1992 10.1016/0002-8703(92)90643-A The effects of intravenous infusions of selective adenosine A1-receptor and A2-receptor agonists on myocardial reperfusion injury 

  18. Cardiovasc Res Budde 47 294 2000 10.1016/S0008-6363(00)00115-2 Comparative study of AMP579 and adenosine in inhibition of neutrophil-mediated vascular and myocardial injury during 24 h of reperfusion 

  19. Circulation Baxter 102 (Suppl. II) II 2000 Amp579, an A1/A2A agonist, limits infarct size at reperfusion via a P42/P44 MAPK-dependent pathway (Abstract) 

  20. Circulation Murry 74 1124 1986 10.1161/01.CIR.74.5.1124 Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium 

  21. Circulation Liu 84 350 1991 10.1161/01.CIR.84.1.350 Protection against infarction afforded by preconditioning is mediated by A1adenosine receptors in rabbit heart 

  22. Cardiovasc Res Tsuchida 26 456 1992 10.1093/cvr/26.5.456 Role of adenosine receptor activation in myocardial infarct size limitation by ischaemic preconditioning 

  23. J Mol Cell Cardiol Grover 32 677 2000 10.1006/jmcc.2000.1111 ATP-sensitive potassium channels: a review of their cardioprotective pharmacology 

  24. J Mol Cell Cardiol Zhao 24 (Suppl. III) S.8 1992 Receptor-mediated reduction of myocardial infarct size and attenuated no-reflow by endogIenous adenosine during ischemia and reperfusion (Abstract) 

  25. J Cardiovasc Electrophysiol Baines 10 741 1999 10.1111/j.1540-8167.1999.tb00251.x Signal transduction in ischemic preconditioning: the role of kiInases and mitochondrial KATPchannels 

관련 콘텐츠

저작권 관리 안내
섹션별 컨텐츠 바로가기

AI-Helper ※ AI-Helper는 오픈소스 모델을 사용합니다.

AI-Helper 아이콘
AI-Helper
안녕하세요, AI-Helper입니다. 좌측 "선택된 텍스트"에서 텍스트를 선택하여 요약, 번역, 용어설명을 실행하세요.
※ AI-Helper는 부적절한 답변을 할 수 있습니다.

선택된 텍스트

맨위로